Structural perspective demonstrates that PfAMA1 domain 2 loop dynamics govern cryptic pocket formation during malaria invasion, indicating targets for durable inhibitor design.
Protein loops often mediate dynamic, conformation-dependent molecular recognition. This perspective examines the essential interaction between Plasmodium falciparum apical membrane antigen 1 (PfAMA1) and rhoptry neck protein 2 (PfRON2), which drives moving-junction formation and erythrocyte invasion. We focus on the PfAMA1 domain 2 (D2) loop and its role in regulating native and therapeutic peptide binding. D2-loop closure creates a cryptic subpocket, termed Hotspot-3, through hydrophobic packing reinforced by hydrogen bonds. This conformational heterogeneity complicates structure-based inhibitor design because binders must either stabilize preferred loop states or accommodate loop dynamics. These findings highlight residence-time optimization, rather than affinity alone, as a key objective for next-generation PfAMA1 inhibitors. Small molecules may also target PfAMA1, although the ligandability of Hotspot-3 remains unproven. Strategies combining N-terminal helicity, cryptic-pocket engagement, conformational-ensemble modelling, and machine learning may enable longer-acting and potentially strain-transcending antimalarial therapeutics. However, Hotspot-3 conservation and sustained inhibition require validation across divergent PfAMA1 alleles.
No takes yet. Share an insight, caveat, or question.
Suman Sinha (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: